Table 7.

ADME properties of DAHA

Derivative	HBD	HBA	MR	TPSA A2	GI absorption	BBB permaent	CYP1A2 inhibitor	LogKp (cm/s)	Lipinski violations	Bioavailability score
DAHA	3	4	38.14	89.34	High	No	No	– 9.36	Yes	0.55
l-lysine acetate	4	6	51.64	126.64	High	No	No	– 11.49	Yes	0.55
l-lysine hydrochloride	3	4	45.11	89.34	High	No	No	– 9.01	Yes	0.55
l-Lysinamide	3	3	39.28	95.13	High	No	No	– 8.19	Yes	O.55
l-lysine diisocyanate	0	6	55.98	85.16	High	No	No	– 5.32	Yes	0.55